45 results
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
and Supply Chain Francis Michael Conway VP, Controller Carole Ben-Maimon, MD Chief Executive Officer Mohamed Hamdani VP, Biometrics Jennifer Johansson, JD VP
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
-clinical R&D Noreen Scherer VP, Clinical Operations Michael Celano Chief Financial Officer Keith E. Lynch, Jr. VP, Manufacturing and Supply Chain Francis
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
14 Sep 22
Other Events
7:05am
Berman, CPA Noreen Scherer Francis Michael Conway VP, Discovery & Non-clinical R&D VP, Manufacturing and Supply Chain VP, Finance & Operations VP
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
Celano Chief Financial Officer Keith E. Lynch, Jr. VP, Manufacturing and Supply Chain Francis Michael Conway VP, Controller Carole Ben-Maimon, MD Chief
8-K
EX-99.2
rirtyjev4
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
skydwkkup0h7
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
3y9pnn79y5w lcygy8pz
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.2
ym8lg5lfe icx59rnf0
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
mq1qjym0t7e8ho6rnn
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
fky6z1f5u ymd
1 Jul 21
Other Events
6:11am
8-K
EX-99.1
xzbo hk6orbyg6duz
14 Jun 21
Other Events
5:21pm
8-K
EX-99.1
9ygam 1a8gqw
18 May 21
Other Events
3:09pm
8-K
EX-99.1
603ilmdefb7m4 2lfb
8 Dec 20
Regulation FD Disclosure
7:40am
8-K
EX-99.2
a68yeff44i
10 Nov 20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
4:23pm
8-K/A
EX-99.2
he5dxh8
26 Jun 20
Other Events
5:08pm
DEFM14A
2lqon9 ig5h
29 Apr 20
Proxy related to merger
3:20pm